Clinical Trial Update: Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study. [Phase 4]

View source ↗

Summary

A Phase 4 pilot study of perampanel for adults with refractory focal epilepsy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC | Conditions: Epilepsy | Phase 4 | Status: TERMINATED